Intercept Pharmaceuticals Inc Beta
What is the Beta of Intercept Pharmaceuticals Inc?
The Beta of Intercept Pharmaceuticals Inc is 0.00
What is the definition of Beta?
BETA indicates whether a stock is more or less volatile than the market as a whole. A beta less than 1 indicates that the stock is less volatile than the market, while a beta more than 1 indicates that the stock is more volatile. Volatility is measured as the fluctuation of the price around the mean.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with beta similar to Intercept Pharmaceuticals Inc
- Vision Marine Technologies has Beta of 0.00
- Ely Gold Royalties has Beta of 0.00
- Glacier Lake Resources has Beta of 0.00
- Magnum Mining and Exploration has Beta of 0.00
- Africa Opportunity Fund has Beta of 0.00
- Fulcrum Utility Services has Beta of 0.00
- Intercept Pharmaceuticals Inc has Beta of 0.00
- Gullewa has Beta of 0.00
- S.A.L. Steel has Beta of 0.00
- Andina Acquisition III has Beta of 0.00
- Andina Acquisition III has Beta of 0.00
- Brilliant Acquisition has Beta of 0.00
- Indokem has Beta of 0.00